Copy number variants signature in two patients with relapsed acute promyelocytic leukemia.
Jacopo Nanni(Istituto di Ematologia di Bologna), Luca Bertamini(University of Verona), Andrea Ghelli Luserna di Rorà(Fondazione Pisa), Maria Chiara Fontana(Istituto Oncologico Romagnolo), Maria Chiara Abbenante(University of Bologna), Emanuela Ottaviani(University of Bologna), Giovanni Marconi(University of Bologna), Silvia Lo Monaco(University of Bologna), Valentina Robustelli(University of Bologna), Eugenia Franchini(University of Bologna), Cristina Papayannidis(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Giorgia Simonetti(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Nicoletta Testoni(Thrombolysis in Myocardial Infarction Study Group), Antonella Padella(University of Bologna), Giovanni Martinelli(University of Bologna), Carmen Baldazzi(University of Bologna), Stefania Paolini(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola)
Cited by 0
Related Papers
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644